A5032243347- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Urologic and reproductive health conditions
- Urinary Tract Infections Management
- Radiopharmaceutical Chemistry and Applications
- Renal cell carcinoma treatment
- Bladder and Urothelial Cancer Treatments
- Urological Disorders and Treatments
- Cancer, Lipids, and Metabolism
- Pelvic floor disorders treatments
- Urinary Bladder and Prostate Research
- Pediatric Urology and Nephrology Studies
- Cryospheric studies and observations
- Advanced Radiotherapy Techniques
- Molecular Biology Techniques and Applications
- Metabolomics and Mass Spectrometry Studies
- Renal and related cancers
- Urinary and Genital Oncology Studies
- Radiomics and Machine Learning in Medical Imaging
- Hormonal and reproductive studies
- Healthcare Systems and Public Health
- Landslides and related hazards
- Legal and Regulatory Analysis
- Medical Imaging Techniques and Applications
- Kidney Stones and Urolithiasis Treatments
Royal Brisbane and Women's Hospital
2016-2025
The University of Queensland
2016-2025
Redcliffe Hospital
2021-2025
The University of Texas Health Science Center at San Antonio
2023-2025
Icelandic Meteorological Office
2007-2024
European Association of Urology
2024
Urological Society of Australia and New Zealand
2014-2023
Nepean Hospital
2019-2023
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
2023
The University of Sydney
2020-2023
<b>Background:</b> Multi-parametric magnetic resonance imaging (mpMRI) is validated for the diagnosis of clinically significant prostate cancer (csPCa). <sup>68</sup>Ga-PSMA -11 PET/CT (PSMA-PET/CT) combined with mpMRI has improved negative predictive value over alone csPCa. The aim this post-hoc analysis PRIMARY study was to evaluate clinical significance patterns intra-prostatic PSMA activity, proposing a 5- point score optimise accuracy PSMA-PET/CT csPCa in low prevalence population....
<sup>68</sup>Ga-labeled prostate-specific membrane antigen (PSMA) PET/CT is increasingly used in men with biochemical recurrence (BCR) after radical prostatectomy (RP), but its longer-term prognostic or predictive potential these unknown. The aim of this study was to evaluate the value PSMA PET for a 3-y freedom from progression (FFP) BCR RP undergoing salvage radiotherapy (sRT). <b>Methods:</b> This prospective multicenter enrolled 260 between 2015 and 2017. Eligible patients were referred...
Different nomograms exist for the preoperative prediction of pelvic lymph-node metastatic disease in individual patients with prostate cancer (PCa). These do not incorporate modern imaging techniques such as prostate-specific membrane antigen (PSMA) positron emission tomography (PET).To determine predictive performance Briganti 2017, Memorial Sloan Kettering Cancer Center (MSKCC), and 2019 addition PSMA-PET an international, multicenter, present-day cohort undergoing robot-assisted radical...
Abstract Multiphoton tomography was used to examine xenobiotic transport in vivo . We the photochemical properties of zinc oxide and fluorescein multiphoton study their skin rat liver Zinc nanoparticles were visualised human using photoluminescence either a selective emission wavelength band pass filter or with fluorescence lifetime imaging (FLIM). (30 nm) did not penetrate into vitro this validated by scanning electron microscopy X‐ray photoelectron spectroscopy. Fluorescein measured FLIM....
The use of emerging nanotechnologies, such as plasmonic nanoparticles in diagnostic applications, potentially offers opportunities to revolutionize disease management and patient healthcare. Despite worldwide research efforts this area, there is still a dearth nanodiagnostics which have been successfully translated for real-world usage due the predominant sole focus on assay analytical performance lack detailed investigations into clinical human samples. In bid address pressing need, we...